Axium PrimeTM APB-2-2-HX-ESRecalls & reported problems
Micro Therapeutics, Inc. · COIL APB-2-2-HX-ES V04 · Class 2 · Implant
All models of Axium PrimeTM (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00847536032163), received between Jan 25, 2022 and May 11, 2023 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Detachment of Device or Device Component2
- Material Deformation1
- Separation Failure1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 11, 2023Detachment of Device or Device Component; Detachment of Device or Device Component
MEDTRONIC RECEIVED A REPORT THAT AN AXIUM COIL HAD PREMATURELY DETACHED. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF AN AMORPHOUS, UNRUPTURED ANEURYSM IN THE LEFT C7 SEGMENT WITH A MAX DIAMETER OF 6.5 X 6.2 MM AND A 3.5 MM NECK DIAMETER. IT WAS NOTED THE PATIENT'S BLOOD FLOW WAS NORMAL AND VESSEL TORTUOSITY WAS NORMAL. IT WAS REPORTED THAT THE DETACHABLE SPRING COIL APB-2-2-HX-ES ACCIDENTALLY DETACHED EARLY WHEN PASSING THROUGH THE Y VALVE, AND COULD NOT CONTINUE TO DELIVER. SUBSEQUENT REPLACEMENT OF OTHER COIL COULD BE DELIVERED NORMALLY AT THE Y VALVE. THE OPERATOR BELIEVED THAT THE COIL WAS A QUALITY PROBLEM. IT WAS REPORTED THERE WAS COIL SEPARATION/BREAK/PREMATURE DETACHMENT. IT WAS REPORTED THE COIL HAD NOT ENTERED THE HUMAN BODY, HAD BEEN TAKEN OUT. THERE WERE NO SURGICAL OR MEDICINAL INTERVENTIONS REQUIRED. THE PUSHWIRE WAS NOT BENT OR BROKEN. THERE WAS NO FRICTION OR DIFFICULTY DURING DELIVERY. THE PHYSICIAN DID NOT REPOSITION THE COIL. THE PHYSICIAN DID NOT ATTEMPT TO DETACH THE COIL. THE PHYSICIAN DID NOT ROTATE THE DELIVERY PUSHER DURING THE PROCEDURE. THE CONTINUOUS FLUSH WAS ADMINISTERED DURING THE PROCEDURE. THE REPORTED DEVICE AND ANY ACCESSORY DEVICES WERE
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16910690 ↗MalfunctionJan 25, 2022Separation Failure; Detachment of Device or Device Component; Material Deformation; Separation Failure; Detachment of Device or Device Component; Material Deformation
MEDTRONIC RECEIVED REPORT THAT WHEN THE AXIUM COIL (MODEL APB-2-2-HX-ES, LOT: B197786) WAS DELIVERED INTO THE ANEURYSM SAC, THE COIL COULD NOT BE DETACHED. THE COIL WAS REMOVED AND REPLACED. IT WAS OBSERVED THAT THE MIDDLE SEGMENT OF THE PUSHER WAS DAMAGED. THERE HAD NOT BEEN ANY FRICTION OR OTHER DIFFICULTY DURING DELIVERY OF THE COIL BUT THE PHYSICIAN DID ROTATE THE PUSHER. WHEN THE AXIUM COIL (MODEL: APB-1.5-2-HX-ES, LOT: 222087536) WAS BEING DELIVERED, THE TIP OF THE COIL WAS STRETCHED SO THE DEVICE WAS REMOVED AND REPLACED. IT WAS NOTED THERE WAS NO FRICTION OR OTHER DIFFICULTY DURING DELIVERY OF THE COIL. THE PHYSICIAN DID NOT ROTATE THE PUSHER DURING THE DELIVER. INFORMATION IN THE REPORT ALSO INDICATED THAT BOTH COILS DETACHED PREMATURELY AS WELL; THE PHYSICIAN HAD NOT ATTEMPTED TO DETACH THE 1.5-2 COIL. IT WAS NOTED THAT ALL DEVICES WERE PREPARED ACCORDING TO THE INSTRUCTIONS FOR USE (IFU). CONTINUOUS CATHETER FLUSH WAS ADMINISTERED DURING THE PROCEDURE. THERE WAS NO HARM OR INJURY TO THE PATIENT WHO WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE TO TREAT A RUPTURED FUSIFORM POSTERIOR COMMUNICATING ARTERY ANEURYSM. THE ANEURYSM MAX DIAMETER 6.1MM AND THE NECK DIAMETER 3.9MM.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13342861 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page